NCT06669078 2024-11-01
NALIRIFOX
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Not yet recruiting
Clinical Trials
7 trialsNCT06429904 2024-05-28
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2 Active not recruiting
NCT05988372 2023-11-01
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06009029 2023-08-24
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
Peking University Third Hospital
Phase 2 Not yet recruiting
NCT04723030 2021-01-25
The Transformation of Locally Advanced Pancreatic Cancer.
Peking University
Phase 2 Unknown
NCT03885219 2020-03-10
Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01063192 2010-02-05
A Study of Locally Advanced Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown